首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1677770

靜脈 (IV) 治療與靜脈通路：全球市場

Intravenous (IV) Therapy and Vein Access: Global Markets

出版日期: 2025年03月04日 | 出版商:

BCC Research | 英文 148 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球靜脈 (IV) 治療和靜脈通路設備市場規模預計將從 2024 年的 570 億美元成長到 2029年終的 744 億美元，在預測期內（2024-2029 年）的複合年成長率為 5.5%。

解決方案和套件部分預計將從 2024 年的 303 億美元成長到 2029年終的397 億美元，預測期間的複合年成長率為 5.5%。輸液幫浦市場預計將從 2024 年的 170 億美元成長到 2029年終的 216 億美元，複合年成長率為 4.9%。

本報告研究了全球靜脈（IV）治療和靜脈通路設備市場，並提供了市場的全面概述，包括市場影響因素和市場機會、法律制度、新興技術和技術發展趨勢、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭格局以及主要企業的概況。

概述
市場促進因素
全球老化
慢性病增加
對改善護理品質的期望
替代設施和居家醫療
靜脈血栓栓塞症和醫院內感染的全球負擔
市場限制
感染疾病和併發症的風險
報銷政策
市場機會
技術進步
新興市場醫療成本上漲
市場挑戰
監管挑戰
安全問題和召回

第4章市場區隔分析

概述
細分市場
按產品類型進行的市場分析
輸液解決方案和套件
點滴幫浦
靜脈通路設備（靜脈導管）
市場分析：按應用
市場規模及預測
醫院
替代照護環境
在家工作
地理分佈
市場分析：按地區
北美洲
歐洲
亞太地區
其他地區

第 5 章新興趨勢與技術

概述
用於血管通路的骨內輸注系統的進展。
抗菌塗層套裝
無針頭連接器
IV 濾波器
智慧靜脈可視化及接取設備
智慧型靜脈輸液設備
輸血器
靜脈注射治療中的無線感測網路和人工智慧
靜脈治療和靜脈通路的進展

第6章 ESG 趨勢

ESG 在靜脈治療和靜脈通路行業
主要製造商的 ESG 永續性
ESG風險評估
BCC 的看法

第7章專利分析

靜脈治療及靜脈通路專利

第8章競爭格局

主要企業市場佔有率分析
Start-Ups和其他有趣的公司
併購/合作
策略聯盟

第 9 章附錄

調查方法
來源
簡稱
公司簡介
ANGIODYNAMICS
BAXTER
B. BRAUN SE
BD
CARDINAL HEALTH
COOK
FRESENIUS SE & CO. KGAA
ICU MEDICAL INC.
INTEGRATED MEDICAL SYSTEMS INC.
IRADIMED CORP.
MEDTRONIC
PFIZER INC.
TERUMO CORP.
VYGON SAS
WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.

簡介目錄圖表

Product Code: HLC046F

The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.

The IV solutions and sets market is expected to grow from $30.3 billion in 2024 and is projected to reach $39.7 billion by the end of 2029, at a CAGR of 5.5% during the forecast period of 2024 to 2029.

The infusion pumps market is expected to grow from $17.0 billion in 2024 and is projected to reach $21.6 billion by the end of 2029, at a CAGR of 4.9% during the forecast period of 2024 to 2029.

Report Scope

This report examines the global market for IV therapy and venous access devices, providing a comprehensive review of applications across several healthcare facility settings.

The study covers a range of IV solutions and devices used in therapeutic applications. BCC Research has analyzed critical market components, including types of IV solutions. These include general IV solutions, parenteral nutrition IV solutions and premixed drug IV solutions; infusion pumps such as general infusion pumps, specialized infusion pumps, portable and disposable infusion pumps, and implantable infusion pumps; and venous access devices such as peripheral IV catheters and central venous catheters.

Products for each IV solution and set market segment include:
General IV solutions and sets: Includes normal saline, hypertonic saline, Lactated Ringer's, Dextran and dextrose in water, along with IV sets, containers and accessories for care settings.
Parenteral nutrition IV solutions and sets: Covers nutrient-rich solutions (carbohydrates, lipid emulsions, amino acids, trace elements, vitamins, minerals) with accompanying IV sets and accessories for care settings.
Premixed IV solutions and sets: Includes premixed drugs (antibiotics, pain management, cardiovascular agents) with drug-delivery systems, containers, and accessories for care settings.

This report addresses regulatory aspects, including technological advances (patents and approvals), and the latest trends, preferences and developments in IV therapy. It includes market projections and market share analysis for global IV therapy and venous access market. It covers emerging technologies, such as AI-integrated ultrasonography for automatic vein measurement to prevent IV catheter failure, and AI-enabled, ultrasound-guided handheld robotic devices for femoral vascular. The market is segmented by region into North America, Asia-Pacific, Europe, and Rest of the World (RoW), and analyzes the markets for the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.

Report Includes

92 data tables and 53 additional tables
Analyses of the global market trends for intravenous (IV) therapy and vein access devices, with revenue data (sales figures) from 2021-2023, forecasts for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type, application, end user and region
Discussion of the market potential and opportunities in the medical device industry, along with an analysis of the competitive environment, regulatory scenario, and technological advances
Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors
Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Patent analysis featuring key granted and published patents
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Company profiles, including BD, B. Braun, Fresenius SE & Co. KGaA, Baxter, and Medtronic

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Market Definition
IV Therapy Overview
Human Circulatory System
Definition of Infusion Therapy
Definition of IV Therapy
Methods of IV Infusion Pump
Pump Infusion
Drip Infusion
History of IV Therapy
IV Solutions
General IV Solutions
Parenteral Nutrition IV Solutions
Premixed Drug IV Solutions
IV Infusion Pumps
Venous Access Devices (IV Catheters)

Chapter 3 Market Dynamics

Overview
Market Drivers
Growing Aging Population Worldwide
Growing Prevalence of Chronic Diseases
Expectations for Increased Quality of Care
Alternative Site and Home-based Medical Care
Global Burden of VTE and Hospital-Acquired Infections
Market Restraints
Risk of Infections and Complications
Reimbursement Policies
Market Opportunities
Technological Advances
Growing Healthcare Spending in Emerging Markets
Market Challenges
Regulatory Challenges
Safety Issues and Recalls

Chapter 4 Market Segment Analysis

Overview
Segmentation Breakdown
Market Analysis by Product Type
IV Solutions and Sets
Infusion Pumps
Venous Access Devices (IV Catheters)
Market Analysis by Application
Market Size and Forecast
Hospitals
Alternative Care Settings
Home-based
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 5 Emerging Trends and Technologies

Overview
Advances in Intraosseous Infusion Systems for Vascular Access
Antimicrobial-Coated Sets
Needleless Connectors
IV Filters
Smart Vein Visualization and Access Devices
Smart IV Devices
Blood Transfusion Sets
Wireless Sensor Networks and AI in IV Therapy
Advances in IV Therapy and Venous Access

Chapter 6 ESG Developments

ESG in the IV Therapy and Venous Access Industry
ESG Sustainability of Major Manufacturers
ESG Risk Ratings
BCC Research Viewpoint

Chapter 7 Patent Analysis

IV Therapy and Venous Access Patents

Chapter 8 Competitive Landscape

Analysis of Leading Companies' Market Shares
Startups and Other Interesting Companies
Mergers, Acquisitions and Collaborations
Strategic Alliances

Chapter 9 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ANGIODYNAMICS
BAXTER
B. BRAUN SE
BD
CARDINAL HEALTH
COOK
FRESENIUS SE & CO. KGAA
ICU MEDICAL INC.
INTEGRATED MEDICAL SYSTEMS INC.
IRADIMED CORP.
MEDTRONIC
PFIZER INC.
TERUMO CORP.
VYGON SAS
WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.

簡介目錄圖表

List of Tables

Summary Table : Global Market for IV Therapy and Venous Access Devices, by Product Type, Through 2029
Table 1 : History of IV Therapy, 1628-2007
Table 2 : Common Examples of General IV Solutions
Table 3 : Number and Percentage of People 65 and over, by Development Group, 2023 and 2050
Table 4 : Number of Persons 65 and over, by WHO Region, 2019 and 2050
Table 5 : Projected Number of U.S. Adults 50 and Older with One or More Chronic Condition, 2020-2050
Table 6 : Major Recalled Products in 2023, FDA
Table 7 : Global Market for IV Therapy and Venous Access Devices, by Product Type, Through 2029
Table 8 : Global Market for IV Solutions and Sets, by Region, Through 2029
Table 9 : Global Market for IV Solutions and Sets, by Type, Through 2029
Table 10 : Global Market for General IV Solutions and Sets, by Region, Through 2029
Table 11 : Global Market for Parenteral Nutrition IV Solutions and Sets, by Region, Through 2029
Table 12 : Global Market for Premixed Drug IV Solutions, by Region, Through 2029
Table 13 : Global Market for Other IV Solutions and Sets, by Region, Through 2029
Table 14 : Global Market for Infusion Pumps, by Region, Through 2029
Table 15 : Global Market for Infusion Pumps, by Type, Through 2029
Table 16 : Global Market for General Infusion Pumps, by Region, Through 2029
Table 17 : Global Market for Specialized Infusion Pumps, by Region, Through 2029
Table 18 : Global Market for Portable and Disposable Infusion Pumps, by Region, Through 2029
Table 19 : Global Market for Implantable Infusion Pumps, by Region, Through 2029
Table 20 : Global Market for Venous Access Devices (IV Catheters), by Region, Through 2029
Table 21 : Global Market for Venous Access Devices (IV Catheters), by Type, Through 2029
Table 22 : Global Market for PIVCs, by Region, Through 2029
Table 23 : Global Market for CVCs, by Region, Through 2029
Table 24 : Global Market for IV Therapy and Venous Access, by Application, Through 2029
Table 25 : Global Market for Hospital-based IV Therapy and Venous Access Products, by Region, Through 2029
Table 26 : Barriers and Facilitators to the Uptake of IV Therapies in Ambulatory Patients, 2024
Table 27 : Global Market for IV Therapy and Venous Access Products for Use in Alternative Care Settings, by Region, Through 2029
Table 28 : Global Market for Home Healthcare-based IV Therapy and Venous Access Products, by Region, Through 2029
Table 29 : Global Market for IV Therapy and Venous Access Devices, by Region, Through 2029
Table 30 : North American Market for IV Therapy and Venous Access, by Product, Through 2029
Table 31 : North American Market for IV Solutions and Sets, by Type, Through 2029
Table 32 : North American Market for Infusion Pumps, by Type, Through 2029
Table 33 : North American Market for Venous Access Devices (IV Catheters), by Type, Through 2029
Table 34 : North American Market for IV Therapy and Venous Access, by Application, Through 2029
Table 35 : North American Market for IV Therapy and Venous Access, by Country, Through 2029
Table 36 : U.S. Market for IV Therapy and Venous Access, by Product, Through 2029
Table 37 : U.S. Market for IV Therapy and Venous Access, by Application, Through 2029
Table 38 : Canadian Market for IV Therapy and Venous Access, by Product, Through 2029
Table 39 : Canadian Market for IV Therapy and Venous Access, by Application, Through 2029
Table 40 : Mexican Market for IV Therapy and Venous Access, by Product, Through 2029
Table 41 : Mexican Market for IV Therapy and Venous Access, by Application, Through 2029
Table 42 : European Market for IV Therapy and Venous Access, by Product, Through 2029
Table 43 : European Market for IV Solutions and Sets, by Type, Through 2029
Table 44 : European Market for Infusion Pumps, by Type, Through 2029
Table 45 : European Market for Venous Access Devices (IV Catheters), by Type, Through 2029
Table 46 : European Market for IV Therapy and Venous Access, by Application, Through 2029
Table 47 : European Market for IV Therapy and Venous Access, by Country, Through 2029
Table 48 : U.K. Market for IV Therapy and Venous Access, by Product, Through 2029
Table 49 : U.K. Market for IV Therapy and Venous Access, by Application, Through 2029
Table 50 : French Market for IV Therapy and Venous Access, by Product, Through 2029
Table 51 : French Market for IV Therapy and Venous Access, by Application, Through 2029
Table 52 : Italian Market for IV Therapy and Venous Access, by Product, Through 2029
Table 53 : Italian Market for IV Therapy and Venous Access, by Application, Through 2029
Table 54 : Leading Causes of Germany's Disease Burden, by DALYs (Level 3), 2022
Table 55 : German Market for IV Therapy and Venous Access, by Product, Through 2029
Table 56 : German Market for IV Therapy and Venous Access, by Application, Through 2029
Table 57 : Spanish Market for IV Therapy and Venous Access, by Product, Through 2029
Table 58 : Spanish Market for IV Therapy and Venous Access, by Application, Through 2029
Table 59 : Rest of European Market for IV Therapy and Venous Access, by Product, Through 2029
Table 60 : Rest of European Market for IV Therapy and Venous Access, by Application, Through 2029
Table 61 : Asia-Pacific Market for IV Therapy and Venous Access, by Product, Through 2029
Table 62 : Asia-Pacific Market for IV Solutions and Sets, by Type, Through 2029
Table 63 : Asia-Pacific Market for Infusion Pumps, by Type, Through 2029
Table 64 : Asia-Pacific Market for Venous Access Devices, by Type, Through 2029
Table 65 : Asia-Pacific Market for IV Therapy and Venous Access, by Application, Through 2029
Table 66 : Asia-Pacific Market for IV Therapy and Venous Access, by Country, Through 2029
Table 67 : Chinese Market for IV Therapy and Venous Access, by Product, Through 2029
Table 68 : Chinese Market for IV Therapy and Venous Access, by Application, Through 2029
Table 69 : Indian Market for IV Therapy and Venous Access, by Product, Through 2029
Table 70 : Indian Market for IV Therapy and Venous Access, by Application, Through 2029
Table 71 : Japanese Market for IV Therapy and Venous Access, by Product, Through 2029
Table 72 : Japanese Market for IV Therapy and Venous Access, by Application, Through 2029
Table 73 : Approved Substitute Overseas-Registered IV Fluids Under Section 19A of the Therapeutic Goods Act 1989 for 2025
Table 74 : Australian Market for IV Therapy and Venous Access, by Product, Through 2029
Table 75 : Australian Market for IV Therapy and Venous Access, by Application, Through 2029
Table 76 : South Korean Market for IV Therapy and Venous Access, by Product, Through 2029
Table 77 : South Korean Market for IV Therapy and Venous Access, by Application, Through 2029
Table 78 : Rest of Asia-Pacific Market for IV Therapy and Venous Access, by Product, Through 2029
Table 79 : Rest of Asia-Pacific Market for IV Therapy and Venous Access, by Application, Through 2029
Table 80 : RoW Market for IV Therapy and Venous Access, by Product, Through 2029
Table 81 : RoW Market for IV Solutions and Sets, by Type, Through 2029
Table 82 : RoW Market for Infusion Pumps, by Type, Through 2029
Table 83 : RoW Market for Venous Access Devices, by Type, Through 2029
Table 84 : RoW Market for IV Therapy and Venous Access, by Application, Through 2029
Table 85 : ESG Steps Taken by Leading Companies, 2023
Table 86 : ESG Risk Rankings for IV Therapy and Venous Access Manufacturing Firm, 2023
Table 87 : Mergers and Acquisitions in the IV Therapy and Venous Access Industry, 2021-2024
Table 88 : Strategic Alliances in the IV Therapy and Venous Access Market, 2021-2024
Table 89 : Information Sources in this Report
Table 90 : Abbreviations Used in This Report
Table 91 : AngioDynamics: Company Snapshot
Table 92 : AngioDynamics: Financial Performance, FY 2022 and 2023
Table 93 : AngioDynamics: Product Portfolio
Table 94 : AngioDynamics: News/Key Developments, 2023 and 2024
Table 95 : Baxter: Company Snapshot
Table 96 : Baxter: Financial Performance, FY 2022 and 2023
Table 97 : Baxter: Product Portfolio
Table 98 : Baxter: News/Key Developments, 2024
Table 99 : B. Braun SE: Company Snapshot
Table 100 : B. Braun SE: Financial Performance, FY 2022 and 2023
Table 101 : B. Braun SE: Product Portfolio
Table 102 : B. Braun SE: News/Key Developments, 2022-2024
Table 103 : BD: Company Snapshot
Table 104 : BD: Financial Performance, FY 2023 and 2024
Table 105 : BD: Product Portfolio
Table 106 : BD: News/Key Developments, 2022-2024
Table 107 : Cardinal Health: Company Snapshot
Table 108 : Cardinal Health: Financial Performance, FY 2022 and 2023
Table 109 : Cardinal Health: Product Portfolio
Table 110 : Cardinal Health: News/Key Developments, 2024
Table 111 : Cook: Company Snapshot
Table 112 : Cook: Product Portfolio
Table 113 : Cook: News/Key Developments, 2024
Table 114 : Fresenius SE & Co. KGaA: Company Snapshot
Table 115 : Fresenius SE & Co. KGaA: Financial Performance, FY 2022 and 2023
Table 116 : Fresenius SE & Co. KGaA: Product Portfolio
Table 117 : Fresenius SE & Co. KGaA: News/Key Developments, 2023 and 2024
Table 118 : ICU Medical Inc.: Company Snapshot
Table 119 : ICU Medical Inc.: Financial Performance, FY 2022 and 2023
Table 120 : ICU Medical Inc.: Product Portfolio
Table 121 : ICU Medical Inc.: News/Key Developments, 2022-2024
Table 122 : Integrated Medical Systems Inc.: Company Snapshot
Table 123 : Integrated Medical System Inc.: Product Portfolio
Table 124 : Integrated Medical Systems Inc.: News/Key Developments, 2023 and 2024
Table 125 : IRadimed Corp.: Company Snapshot
Table 126 : IRadimed Corp.: Financial Performance, FY 2022 and 2023
Table 127 : IRadimed Corp.: Product portfolio
Table 128 : IRadimed Corp.: News/Key Developments, 2023
Table 129 : Medtronic: Company Snapshot
Table 130 : Medtronic: Financial Performance, FY 2022 and 2023
Table 131 : Medtronic: Product Portfolio
Table 132 : Medtronic: News/Key Developments, 2022 and 2023
Table 133 : Pfizer Inc.: Company Snapshot
Table 134 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 135 : Pfizer Inc.: Product Portfolio
Table 136 : Pfizer Inc.: News/Key Developments, 2022-2024
Table 137 : Terumo Corp.: Company Snapshot
Table 138 : Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 139 : Terumo Corp.: Product Portfolio
Table 140 : Terumo Corp.: News/Key Developments, 2023 and 2024
Table 141 : Vygon SAS: Company Snapshot
Table 142 : Vygon SAS: Product Portfolio
Table 143 : Wellmed International Industries Pvt. Ltd.: Company Snapshot
Table 144 : Wellmed International Industries Pvt. Ltd.: Product Portfolio

List of Figures

Summary Figure : Global Market for IV Therapy and Venous Access Devices, by Product Type, 2021-2029
Figure 1 : Snapshot of the Market Dynamics for IV Therapy and Venous Access Devices
Figure 2 : Distribution of New Cases of Cancer, by WHO Region, 2022
Figure 3 : Distribution of Cancer Mortality Cases, by WHO Region, 2022
Figure 4 : Global Market Shares of IV Therapy and Venous Access Devices, by Product Type, 2023
Figure 5 : Global Market Shares of IV Solutions and Sets, by Type, 2023
Figure 6 : Global Market Shares of Infusion Pumps, by Type, 2023
Figure 7 : Global Market Shares of Venous Access Devices (IV Catheters), by Type, 2023
Figure 8 : Global Market Shares of IV Therapy and Venous Access, by Application, 2023
Figure 9 : Global Market Shares of IV Therapy and Venous Access Devices, by Region, 2023
Figure 10 : North American Market Shares of IV Therapy and Venous Access, by Country, 2023
Figure 11 : European Market Shares of IV Therapy and Venous Access, by Country, 2023
Figure 12 : Asia-Pacific Market Shares of IV Therapy and Venous Access, by Country, 2023
Figure 13 : 2024 Progress Assessment: Tracking the Sustainable Development Goals
Figure 14 : Patents Documented, by Owner, January 2021 to November 2024
Figure 15 : Share of Patents Documented, by Jurisdiction, January 2021 to November 2024
Figure 16 : Patents Documented Over Time, January 2010 to November 2024
Figure 17 : Leading Companies' Shares of Global Market for IV Therapy and Venous Access Devices, 2023
Figure 18 : AngioDynamics: Revenue Shares, by Business Unit, FY 2023
Figure 19 : AngioDynamics: Revenue Shares, by Country/Region, FY 2023
Figure 20 : Baxter: Revenue Shares, by Business Unit, FY 2023
Figure 21 : Baxter: Revenue Shares, by Country/Region, FY 2023
Figure 22 : B. Braun SE: Revenue Shares, by Business Unit, FY 2023
Figure 23 : B. Braun SE: Revenue Shares, by Country/Region, FY 2023
Figure 24 : BD: Revenue Shares, by Business Unit, FY 2024
Figure 25 : BD: Revenue Shares, by Country/Region, FY 2024
Figure 26 : Cardinal Health: Revenue Shares, by Business Unit, FY 2023
Figure 27 : Cardinal Health: Revenue Shares, by Country/Region, FY 2023
Figure 28 : Fresenius SE & Co. KGaA: Revenue Shares, by Business Unit, FY 2023
Figure 29 : Fresenius SE & Co. KGaA: Revenue Shares, by Country/Region, FY 2023
Figure 30 : ICU Medical Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 31 : ICU Medical Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 32 : IRadimed Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 33 : IRadimed Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 34 : Medtronic: Revenue Shares, by Business Unit, FY 2023
Figure 35 : Medtronic: Revenue Shares, by Country/Region, FY 2023
Figure 36 : Pfizer Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 37 : Pfizer Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 38 : Terumo Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 39 : Terumo Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 40 : Vygon SAS: Revenue Shares, by Business Unit, FY 2023